Ligand validation:6LIN

EH0: 4-[[[4-[3,5-bis(fluoranyl)-4-(4-oxidanyl-4-oxidanylidene-butoxy)phenyl]-5-[5-chloranyl-2,4-bis(oxidanyl)phenyl]-1,2-oxazol-3-yl]carbonylamino]methyl]benzoic acid

EH0 is a Ligand Of Interest in 6LIN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LIN_EH0_A_403	40%	5%	0.207	0.92	1.51	3.95	7	19	0	0	100%	1
6LIN_EH0_C_402	38%	18%	0.198	0.899	1.46	2.26	6	15	0	0	100%	1
6LIN_EH0_B_402	37%	12%	0.23	0.927	1.67	2.52	6	15	0	0	100%	1
6LIN_EH0_D_401	27%	12%	0.246	0.893	1.46	2.73	5	15	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.